Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation
Standard
Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation. / Huss, R; Gatsios, P; Graeve, L; Lange, Claudia; Eissner, G; Kolb, H J; Thalmeier, K; Heinrich, P C.
In: CYTOKINE, Vol. 12, No. 8, 01.08.2000, p. 1195-204.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation
AU - Huss, R
AU - Gatsios, P
AU - Graeve, L
AU - Lange, Claudia
AU - Eissner, G
AU - Kolb, H J
AU - Thalmeier, K
AU - Heinrich, P C
N1 - Copyright 2000 Academic Press.
PY - 2000/8/1
Y1 - 2000/8/1
N2 - The CD34-negative, adherent growing, fibroblast-like canine haematopoietic stem cell line D064 was recently identified as the earliest progenitor population in the bone marrow. D064 cells are predominately quiescent. Quiescence is mediated by the accumulation of the cyclin-dependent kinase inhibitor p27(kip-1)and in parallel, by the downregulation of Cyclin B, leading to an accumulation of quiescent cells in the G(0)/G(1)-phase of the cell cycle. Stem cell factor (SCF), the ligand for the tyrosine kinase receptor c-kit, usually induces differentiation of the CD34-negative stem cells into CD34-positive haematopoietic precursors. SCF also suppresses the expression of c-myc-dependent Cyclin E, which is not transcribed initially, but expression occurs later on. Interleukin 6 (IL-6) instead rather promotes proliferation, but fails to induce proliferation in the majority of CD34-negative stem cells due to no STAT activation in quiescent cells. Nevertheless, the potential of quiescent D064 cells to proliferate eventually, becomes apparent by the low-level expression of IL-6 dependent STAT factors. D064 cells also spontaneously start to express Bax, while Bcl-2 is downregulated in parallel. In summary, CD34-negative haematopoietic stem cells dwell in the marrow or other niches as quiescent cells, until they can respond to autocrine or paracrine growth factor-mediated signals.
AB - The CD34-negative, adherent growing, fibroblast-like canine haematopoietic stem cell line D064 was recently identified as the earliest progenitor population in the bone marrow. D064 cells are predominately quiescent. Quiescence is mediated by the accumulation of the cyclin-dependent kinase inhibitor p27(kip-1)and in parallel, by the downregulation of Cyclin B, leading to an accumulation of quiescent cells in the G(0)/G(1)-phase of the cell cycle. Stem cell factor (SCF), the ligand for the tyrosine kinase receptor c-kit, usually induces differentiation of the CD34-negative stem cells into CD34-positive haematopoietic precursors. SCF also suppresses the expression of c-myc-dependent Cyclin E, which is not transcribed initially, but expression occurs later on. Interleukin 6 (IL-6) instead rather promotes proliferation, but fails to induce proliferation in the majority of CD34-negative stem cells due to no STAT activation in quiescent cells. Nevertheless, the potential of quiescent D064 cells to proliferate eventually, becomes apparent by the low-level expression of IL-6 dependent STAT factors. D064 cells also spontaneously start to express Bax, while Bcl-2 is downregulated in parallel. In summary, CD34-negative haematopoietic stem cells dwell in the marrow or other niches as quiescent cells, until they can respond to autocrine or paracrine growth factor-mediated signals.
KW - Animals
KW - Antigens, CD34
KW - COS Cells
KW - Cell Cycle
KW - Cell Cycle Proteins
KW - Cell Division
KW - Cells, Cultured
KW - Cyclin B
KW - DNA-Binding Proteins
KW - Dogs
KW - Down-Regulation
KW - Hematopoietic Stem Cells
KW - Humans
KW - Interleukin-6
KW - Proto-Oncogene Proteins
KW - Proto-Oncogene Proteins c-bcl-2
KW - Proto-Oncogene Proteins c-myc
KW - STAT1 Transcription Factor
KW - Stem Cell Factor
KW - Trans-Activators
KW - Transcription, Genetic
KW - bcl-2-Associated X Protein
U2 - 10.1006/cyto.1999.0732
DO - 10.1006/cyto.1999.0732
M3 - SCORING: Journal article
C2 - 10930296
VL - 12
SP - 1195
EP - 1204
JO - CYTOKINE
JF - CYTOKINE
SN - 1043-4666
IS - 8
ER -